Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LOPERAMIDA GRINDEKS 2 MG CÁPSULAS DURAS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LOPERAMIDA GRINDEKS 2 MG CÁPSULAS DURAS

Approved

STANDARD

LOPERAMIDA GRINDEKS 2 MG CÁPSULAS DURAS

Grindeks As🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 12, 2023
Approval ID: d5311fc2122d77b8
Company: Grindeks As
Type: Standard

Approval Details

Approval Id: d5311fc2122d77b8
Drug Cima Aemps Name: LOPERAMIDA GRINDEKS 2 MG CÁPSULAS DURAS
Register Number: 89192
Holder Company Name: Grindeks As
Marketing Company Name: Grindeks Kalceks Espana S.L.
Holder Company Detail Path: /organization/grindeks-as
Authorization Date: 2023-12-12
Dosage Form: CÁPSULA DURA
Dose: 2 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Grindeks As
Company Detail Path: /organization/grindeks-as

Company Information

Pharmaceutical Company Name: Grindeks AS
Country Name: Latvia
Website: http://grindeks.eu

Active Ingredients

LOPERAMIDA HIDROCLORURO

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 12, 2023

Approval ID

d5311fc2122d77b8

Type

Standard

Back to CIMA-AEMPS Approvals